Liver transplants from drug overdose deaths rose sharply during COVID-19 pandemic

Credit: CC0 Public Domain

Liver transplants from over-the-counter donors and seeds increased significantly in the first year of the outbreak, helping to maintain the number of liver transplants in the United States despite COVID-19 deficiency, according to a study to be released in Digestive Week Disease (DDW) 2022.

“When the disease started, we did not see a reduction liver transplantwhich seems like a surprise since many surgeries have been canceled or delayed, “said lead author Peter Lymberopoulos, a four-year medical student at St. George University.” Unfortunately, the main reason seems to be the number of donor organs that have died from the disease. the frequency of drug use. “

Using the US Organ Sharing Contribution Registry, administered by the United Network for Organ Sharing, the research team examined the behavior of donors for any potential. transplant organs, including the liver, within 2 months of 14 months, both before and after the onset of the disease. They identified those transmissions from over-the-counter donors and strains to assess the magnitude of the changes during a disaster.

“From liver transplantation, we found that the number of overweight donors increased dramatically in the first 14 months of the epidemic, compared to the previous 14 months,” Lymberopoulos said. “Organ transplants are successful, but they often come at a high cost. young men death early from excess of seed. “

The researchers found that the number of liver transplants from donors who died from overdose and seed increased by 26 percent – from 15.1 percent to 18.3 percent – from the pre-COVID period (January 1, 2019, to February 29, 2020) to COVID period (May 1, 2020, to June 30, 2021). The study excluded transplants that took place in March and April 2020, due to the COVID-related complications in hospitals during these months. For all potential organ transplants, they found that the use of over-the-counter donors increased by 31.2 percent, from 14.2 percent to 17.2 percent.

This study is based on some studies showing an increased contribution of organs from mortality rate in the decades-long opioid crisis in the United States and to record the safety of these transplants. Most of the victims were young, with little or no involvement health conditionsuch as high blood pressure or diabetes, which can affect the organs.

The study did not investigate why liver cirrhosis is associated with higher mortality rates, but researchers report that the underlying disease-related economic factors contribute to increased mortality and are often associated with opioids. since opioids make up almost 70 percent of the deaths in the country.

To build on this research, the team plans to examine additional organ donation data to see if this condition persists until the second year of the epidemic.

Improving the utilization of donated units from mortality rates can help address national organ deficiencies

Learn more:
Use of over-the-counter donors for liver transplants during the COVID-19 disaster, abstract Su1373, Digestive Week 2022.

hint: Liver transplant from high mortality rate significantly increased during COVID-19 disaster (2022, May 22) Retrieved May 22, 2022 from transplants-drug-overdose-deaths.html

This document is copyrighted. Apart from any genuine transaction for the purpose of personal analysis or investigation, no part may be reproduced without our written permission. Content is provided for informational purposes only.

Liver transplants from drug overdose deaths rose sharply during COVID-19 pandemic Source link Liver transplants from drug overdose deaths rose sharply during COVID-19 pandemic

Related Articles

Back to top button